previous compound ID: 2531 next compound
InChIKey: WWYNJERNGUHSAO-XUDSTZEESA-N
SMILES: CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "E Matthes" "R Robert" "SD Macknight" "GW Carlile" "B Kus" "J Liao" "J Goepp" "D Rotin" "DY Thomas"

chemical graph of compound 2531





CID is 13109
synonyms found at PubChem are:
Levonorgestrel, norgestrel, 797-63-7, D-Norgestrel, (-)-Norgestrel, Levonova, Microval, Postinor, Mirena, Jadelle, Neogest, Ovrette, Plan B, NORPLANT, Norplant 2, Follistrel, Microlution, Microgyn, Microlut, Monovar, Ovranette, Triagynon, Triciclor, Trivora, Nordet, Trigoa, 18-Methylnorethisterone, Levonorgestrelum, Microgynon CD, Microgest ED, Norplant II, Logynon ED, Ovral-Lo, Levlen ED, Microgynon 21, Microgynon 28, Trinordiol 21, Trinordiol 28, d(-)-Norgestrel, Minivlar 30, Monofeme 28, Neogynon 21, Nordette 21, Nordette 28, Stediril 30, Levonelle, Trifeme 28, Levlen, Preven, Microgynon 30 ED, Tri-Levlen 21, Levora-21, Levora-28, Rigevidon 21+7, NorLevo, Triquilar ED, LO/Ovral, Triphasil 21, Triphasil 28, LD norgestrel [French], Levonorgestrelum [INN-Latin], Norgestrelum, Norgestrelum [INN-Latin], Capronor, D-(-)-Norgestrel, Nordette, Norgeston, Levonorgestrel implants, E-Gen-C, alpha-Norgestrel, Tri-Levlen, Norgestrel [Progestins], Norplant-2, Ovoplex 30-150, 6533-00-2, Methylnorethindrone, Norgestrel-(-)-D, Wy 3707, Wy-5104, Ld norgestrel, Microluton, Tetragynon, UNII-5W7SIA7YZW, 17-Ethynyl-18-methyl-19-nortestosterone, Postinor-2, Wy-3707, FH 122-A, 17alpha-Ethynyl-18-homo-19-nortestosterone, Norplant System in Plastic Container, SH 850, Norplant (TN), Ovrette (TN), 18-Methyl-17-alpha-ethynyl-19-nortestosterone, dl-Norgestrel, Mirena (TN), CCRIS 6525, CCRIS 9033, component of Lo/ovral, SH 70850, HSDB 3595, HSDB 6483, Levonorgestrel [USAN:INN:BAN], 13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one, 17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one, 17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol, Norgestrel [USAN:BAN:INN:JAN], Norgestrel [USAN:INN:BAN:JAN], 17alpha-Ethynyl-13-ethyl-19-nortestosterone, 13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one, 13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, EINECS 212-349-8, EINECS 229-433-5, 5W7SIA7YZW, 72-HOURS, BRN 2391114, 13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one, 18,19-Dinor-4-pregnen-20-yn-3-one, dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone, DNorgestrel, MLS000069491, CHEBI:6443, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one, Levonorgestrel (JAN/USP/INN), 19-Nortestosterone, 17-ethynyl-18-methyl-, 17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one, SOH-075, 13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, (-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-, 13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one, MFCD00199013, NCGC00159349-02, SMR000059117, dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one, 17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one, 17alpha-Ethynyl-18-homo-19-nor-testosterone, (+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one, 17-alpha-Ethynyl-13-ethyl-19-nortestosterone, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-, DSSTox_CID_16496, DSSTox_RID_79283, DSSTox_GSID_36496, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, Norgestrel (JP15/USP/INN), 17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one, 13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, Levogel, Levosert, Liletta, Skyla, 13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one, Next choice, Fallback Solo, 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE, 18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, 18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-, Plan B One Step, Plan B One-Step, Levonorgestrel (Levonelle), LNG-IUS, Levonelle, D-Norgestrel, Levonova, Levonorgestrel, Kyleena, 1lhv, Oral levonorgestrel, CAS-797-63-7, Prestwick_109, (+-)-Norgestrel, (-)-Levonorgestrel, Levonorgestrel [USAN:USP:INN:BAN], Levonorgestrel implant, Skyla (TN), BAY86-5028, Norgestrel [USAN:USP:INN:BAN:JAN], BAY 86-5028, 18-Methylnorethindrone, Opera_ID_552, AC1Q6OEV, Levonorgestrel(Levonelle), Prestwick0_000773, Prestwick1_000773, Prestwick2_000773, Prestwick3_000773, Intrauterine levonorgestrel, D0A9MR, D0BA9U, D0G6CT, (-)-Norgestrel, 98%, CHEMBL1389, BIDD:PXR0194, SCHEMBL27597, BSPBio_000846, MLS000759484, MLS001074069, MLS001423967, SPBio_002785, 13-Ethyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one, AC1L211U, BPBio1_000932, GTPL2881, Levonelle;D-Norgestrel;Levonova, Norgestrel (JP17/USP/INN), DTXSID3036496, MolPort-002-510-453, WWYNJERNGUHSAO-XUDSTZEESA-N, HMS1570K08, HMS2051M08, HMS2090O06, HMS2097K08, HMS2232H06, HMS2232K12, HMS3649J10, HMS3714K08, (1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one, BCP21999, HY-B0257, ZINC3814395, D-(-)-Norgestrel (Levonorgestrel), Tox21_111593, Tox21_202872, Tox21_303658, BDBM50410522, LMST02030119, NSC744007, s1727, D(-)-Norgestrel, analytical standard, AKOS015894913, Tox21_111593_1, BCP9000852, CCG-100853, CS-2243, DB00367, MCULE-1283162506, NC00103, NSC-744007, [18,(17.alpha.)-(-)-], NCGC00159349-03, NCGC00159349-05, NCGC00257283-01, NCGC00260418-01, AJ-45701, LS-62083, LS-62084, SMR000653526, AB0012485, AB2000252, FT-0658692, N0889, C08149, C08153, D00950, D00954, EN300-122613, 797L637, A835065, SR-01000759218, SR-01000946725, (-)-17alpha-Ethynyl-18-methyl-19-nortestosterone, SR-01000759218-5, SR-01000946725-1, BRD-K35189033-001-03-0, 13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one, Z1551429747, 13beta-ethyl-17alpha-ethynyl-17-hydroxy-gon-4-en-3-one, UNII-3J8Q1747Z2 component WWYNJERNGUHSAO-XUDSTZEESA-N, (17?)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-yn-3-one, 13beta-Ethyl-17alpha-ethynyl-17 beta-hydroxygon-4-en-3-one, 13beta-ethyl-17alpha-ethynyl-17beta-hydroxy-gon-4-en-3-one, Levonorgestrel, European Pharmacopoeia (EP) Reference Standard, 18,19-Dinor-13beta-ethyl-17 beta hydroxy-4-pregnen-20-yn-3-one, 18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one, Levonorgestrel, United States Pharmacopeia (USP) Reference Standard, (-)-18,19-Dinor-13beta-ethyl-17beta-hydroxy-4-pregnen-20-yn-3-one, [(-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one, [18,19-Dinorpregn-4-en-20-yn-3-one-13-ethyl-17-hydroxy-,(17..)-(-)-], 18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+)-, Levonorgestrel for system suitability 2, European Pharmacopoeia (EP) Reference Standard, Levonorgestrel, Pharmaceutical Secondary Standard; Certified Reference Material, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-oxidanyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one, 121714-72-5, 4222-79-1, 797-62-6